LRRK2 and Parkinson disease: Therefore, the LRRK2:G2019S mutation may be an ideal disease model and one potential breakthrough in PD research to determine the mechanisms of PD and to develop new treatment methods by studying PD patients with LRRK2:G2019S variation.